aXichem

1.50 SEK

-2.28 %

Less than 1K followers

AXIC A

First North Stockholm

Chemicals

Basic Materials

Overview

Financials & Estimates

Ownership

Dividend

Investor consensus

-2.28 %

+9.49 %

+13.21 %

-27.01 %

-38.33 %

-44.04 %

-77.10 %

-94.92 %

-91.05 %

aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company works mainly with Phenylcapsaicin, a natural analogue synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, and among individual pharmaceutical work areas. Operations are conducted on a global level, with headquarters in Malmö.

Market cap

101.59M SEK

Turnover

27.22K SEK

Revenue

18.45M

EBIT %

-94.8 %

P/E

-

Dividend yield-%

-

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

17.6

2026

General meeting '26

27.8

2026

Interim report Q2'26

26.11

2026

Interim report Q3'26

All

Press releases

ShowingAll content types

Press release11/10/2022, 6:47 AM

Redeye: aXichem - Essential approvals ahead

Regulatory press release10/27/2021, 6:30 AM

aXichem AB: aXichem secures production capacity for phenylcapsaicin, corresponding to volumes of up to 100 tons of aXiphen-feed, for the upcoming six to nine months

Regulatory press release10/4/2021, 7:00 AM

aXichem AB: aXichem exhibits at Vitafoods Europe 2021 in Geneva, and launches a new website presenting the unique product aXivite

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release9/13/2021, 7:00 AM

aXichem AB: aXichem exhibits at Vitafoods Europe 2021 in Geneva, presenting its innovative product aXivite, with proven significant effect in decrease of body fat

Regulatory press release9/7/2021, 6:50 AM

Redeye: aXichem - Entering the Commercial Phase

Regulatory press release4/12/2021, 1:30 PM

aXichem AB: aXichem's product aXivite[®] is the active ingredient in a new pre-workout drink launched on the Spanish market

Regulatory press release11/24/2020, 11:00 AM

aXichem AB: aXichem signs agreement with BART regarding distribution and sales of aXivite® in Poland

Regulatory press release10/5/2020, 10:20 AM

aXichem AB: aXichem's natural analogue capsaicin, aXivite, is a key ingredient in new consumer product, for histamine intolerance, to be launched in the U.S. market

Regulatory press release10/5/2020, 10:00 AM

aXichem AB: aXichem announces first consumer product for weight loss, with aXivite as an active ingredient, to be launched in the French market by Sarl Myterrapy

Regulatory press release9/25/2020, 4:30 PM

aXichem AB: aXichem presents its natural analogue capsaicin aXivite, together with new marketing material, in series of webinars

Regulatory press release7/20/2020, 10:30 AM

aXichem AB: aXichem obtains order from Actives & Co for aXivite, to be used in product development project for the French market

Regulatory press release7/14/2020, 11:00 AM

aXichem AB: aXichem signs distribution agreement with Berg Nutrition for sales and distribution of aXivite® to the ingredients market in the U.S. and Canada

Regulatory press release3/30/2020, 2:00 PM

aXichem AB: aXichem signs agreement with Actives & Co for sales and distribution of aXivite® in France

Regulatory press release3/3/2020, 9:40 AM

aXichem AB: aXichem signs distribution agreement with Tecom Ingredients for sales and distribution of aXivite® in Spain

Regulatory press release2/25/2019, 9:47 AM

aXichem AB: aXichem and Canadian based Iovate sign Letter of Intent regarding development and commercialization of aXivite, as ingredient in weight management supplement

Regulatory press release10/12/2018, 10:45 AM

aXichem launches aXivite®, a new brand for nutraceuticals

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.